Rising Rate of Drug Shortages Is Framed as a National Security Threat
A Senate homeland security committee examined growing health care shortages amid reports of rationing within hospitals....
openexo.com/feed/item/rising…#BioTech#science
How 89bios Phase IIb NASH data match up with Akeros in FGF21 class
DATA BYTE HOW 89 BIO’S PHASE IIB NASH DATA MATCH UP WITH AKERO’S IN FGF21 CLASSBY Planned Phase III trials would clarify benefit compar...
openexo.com/feed/item/how-89…#BioTech#science
Genomadix Gets FDA 510(k) Clearance for Point-of-Care PCR System, CYP2C19 Test
Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guid...
openexo.com/feed/item/genoma…#BioTech#science
March 22 Quick Takes: GordonMD,Pfizer Ventures lead Flares $123M B round
QUICK TAKES: GORDONMD, PFIZER VENTURES LEAD FLARE’S $123M B ROUND BY Plus: FDA approvals for Cidara, Incyte and updates from Karuna, As...
openexo.com/feed/item/march-…#BioTech#science
EpiBiologics tapping two lysosomal degradation mechanisms with $50M
EMERGING COMPANY PROFILEEPIBIOLOGICS TAPPING TWO LYSOSOMAL DEGRADATION MECHANISMS WITH $50M BY The UCSF spinout is degrading membrane-b...
openexo.com/feed/item/epibio…#BioTech#science
New CFOs at Remix, Capstan
MANAGEMENT TRACKSNEW CFOS AT REMIX, CAPSTANBY Plus: Maderis to be chair at Durect and updates from Generate and Patient Discovery Solut...
openexo.com/feed/item/new-cf…#BioTech#science
Tofersen panel bolsters case for neurofilament as ALS surrogate endpoint
REGULATIONTOFERSEN PANEL BOLSTERS CASE FOR NEUROFILAMENT AS ALS SURROGATE ENDPOINT BY FDA advisory committee backs accelerated approval...
openexo.com/feed/item/tofers…#BioTech#science
Infusing beans with a new genetic blueprint: Synthetic biology startup engineers soybeans to produce ingredients for cancer drugs, vaccines and infant formula
...
openexo.com/feed/item/infusi…#BioTech#science
Blood for money: my journey in the industry buying poor Americans plasma
The US is one of the few countries that allows donors – who are often struggling economically – to be paid for plasmaI was sitting in t...
openexo.com/feed/item/blood-…#BioTech#science
ThoughtFull gets $4M funding from Temasek's Sheares, other tech founders
It also received backing from the founders of Grab and Zalora....
openexo.com/feed/item/though…#BioTech#science
Hamamatsu beings construction of new Japan-based facility
Hamamatsu Photonics will start the construction of a new factory building to meet the growing demand of the opto-semiconductor device m...
openexo.com/feed/item/hamama…#BioTech#science
Rhisa and Gradient Health data tie-up aims to accelerate innovation
Medical technology companies Rhisa and Gradient Health join forces to accelerate healthcare innovation by providing a new scale of dive...
openexo.com/feed/item/rhisa-…#BioTech#science
Wesper gets FDA nod for next-generation sleep care device
The new device will gather significant clinical-grade longitudinal data to diagnose and monitor treatment efficacy over time...
openexo.com/feed/item/wesper…#BioTech#science
Human Fasting Modulates Macrophage Function
The Journal Club returns on Tuesday 28th March at 12:00 PM Eastern time to the Lifespan.io Facebook channel. This month Dr. Oliver Medv...
openexo.com/feed/item/human-…#BioTech#science
Common Genetic Signature May Increase Risk of Multiple Substance Abuse Disorders
The results of NIH-funded research suggest that a common genetic signature may increase an individual’s risk of developing substance us...
openexo.com/feed/item/common…#BioTech#science
Neutrophils Found to Be Culprits in Treatment-Resistant Pancreatic Cancer
Researchers led by Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown for the first ...
openexo.com/feed/item/neutro…#BioTech#science
BetaLife and A*STAR Agree to Focus on Novel Cell-Based Therapy for Diabetes
BetaLife, a stem cell therapy company working on regenerative medicine for diabetes, acquired the rights to human induced Pluripotent S...
openexo.com/feed/item/betali…#BioTech#science
Ono and Macomics join forces to develop cancer therapy
The partnership will involve progressing macrophage-targeting antibody treatment for cancer...
openexo.com/feed/item/ono-an…#BioTech#science